Miscarriage in a patient with Glanzmann Thrombasthenia and low ovarian reserve: a case report
Abstract
Keywords
References
- 1. Nurden AT. Glanzmann thrombasthenia. Orphanet J Rare Dis. 2006 ;1(1):10.
- 2. Poon MC, Di Minno G, d’Oiron R, Zotz R. New Insights Into the Treatment of Glanzmann Thrombasthenia. Transfusion Medicine Reviews. 2016 ;30(2):92–9.
- 3. Clemetson KJ. Platelets and Primary Haemostasis. Thrombosis Research. 2012 ;129(3):220–4.
- 4. Wijemanne A, Watt-Coote I, Austin S. Glanzmann thrombasthenia in pregnancy: Optimising maternal and fetal outcomes. Obstet Med. 2016 ;9(4):169–70.
- 5. Botero JP, Lee K, Branchford BR, Bray PF, Freson K, Lambert MP, et al. Glanzmann thrombasthenia: genetic basis and clinical correlates. Haematologica. 2020 ;105(4):888–94.
- 6. Nurden AT. Acquired Antibodies to α IIbβ3 in Glanzmann Thrombasthenia: From Transfusion and Pregnancy to Bone Marrow Transplants and Beyond. Transfusion Medicine Reviews. 2018 ;32(3):155–64.
- 7. Yougbaré I, Tai WS, Zdravic D, Oswald BE, Lang S, Zhu G, et al. Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia. Nat Commun. 2017 ;8(1):224.
- 8. Nurden A, Pillois X, Fiore M, Heilig R, Nurden P. Glanzmann Thrombasthenia-Like Syndromes Associated with Macrothrombocytopenias and Mutations in the Genes Encoding the αIIbβ3 Integrin. Semin Thromb Hemost. 2011 ;37(06):698–706.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Case Report
Authors
Mert Sonkaya
0000-0002-2568-4141
Türkiye
Publication Date
October 29, 2022
Submission Date
June 3, 2022
Acceptance Date
July 13, 2022
Published in Issue
Year 2022 Volume: 39 Number: 4
